3 European Penny Stocks With Market Caps Under €2B

The European stock market has recently experienced some turbulence, with the pan-European STOXX Europe 600 Index ending the week down due to global bond sell-offs and inflationary pressures. In this context, penny stocks—typically smaller or newer companies—continue to present intriguing opportunities for investors seeking growth at a lower cost. Despite being an outdated term, penny stocks remain relevant as they can offer significant potential when supported by strong financials and sound fundamentals.

Here's a peek at a few of the choices from the screener.

NX Filtration (ENXTAM:NXFIL)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: NX Filtration N.V. is a company that develops, produces, and sells hollow fiber membrane modules across various regions including the Netherlands, Europe, North America, Asia, and internationally with a market cap of €200.58 million.

Operations: NX Filtration N.V. does not report specific revenue segments, but it operates in regions such as the Netherlands, Europe, North America, Asia, and internationally.

Market Cap: €200.58M

NX Filtration N.V. has shown revenue growth, reporting €7.81 million for the first half of 2026, up from €6.56 million a year prior, though it remains unprofitable with a net loss of €12.35 million. The company maintains a stable cash runway exceeding three years if free cash flow trends continue, supported by short-term assets surpassing both short and long-term liabilities significantly. Despite increased debt levels over five years, NX Filtration holds more cash than total debt and has not diluted shareholders meaningfully in the past year. However, its share price remains highly volatile with no profitability expected in the near term.

• Unlock comprehensive insights into our analysis of NX Filtration stock in this financial health report.
• Examine NX Filtration's earnings growth report to understand how analysts expect it to perform.

Glenveagh Properties (ISE:GVR)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Glenveagh Properties PLC is involved in the construction and sale of houses and apartments for private buyers, local authorities, and the private rental sector in Ireland, with a market cap of €1.24 billion.

Operations: The company's revenue is primarily derived from two segments: Homebuilding, which generated €544.99 million, and Partnerships, contributing €380.89 million.

Market Cap: €1.24B

Glenveagh Properties PLC, with a market cap of €1.24 billion, has demonstrated robust financial stability and growth potential. The company's revenue is driven by its Homebuilding (€544.99 million) and Partnerships (€380.89 million) segments. Its Return on Equity is relatively low at 13.6%, but interest payments are well-covered by EBIT (7.8x coverage). The net debt to equity ratio stands satisfactorily at 20.8%. Profit margins have improved slightly to 11.6%, supported by high-quality earnings and experienced management and board teams with average tenures of seven years and 5.1 years respectively, indicating strong governance practices.

• Click to explore a detailed breakdown of our findings in Glenveagh Properties' financial health report.
• Learn about Glenveagh Properties' future growth trajectory here.

Summa Defence Oyj (OM:SUMMAS)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Summa Defence Oyj is a Finnish defense and security technology group specializing in dual-use technologies, with a market cap of approximately SEK212.65 million.

Operations: The company's revenue segment is primarily from Aerospace & Defense, generating approximately €105.96 million.

Market Cap: SEK212.65M

Summa Defence Oyj, with a market cap of SEK212.65 million, faces challenges typical of penny stocks, including high volatility and financial instability. The company is unprofitable with a negative Return on Equity of -14.39% and has insufficient cash runway for more than four months despite recent capital raising efforts. Its management and board are relatively inexperienced, with average tenures under one year. Recent investor activism has prompted demands for a special audit covering various aspects of the company's administration and accounting practices. Despite these issues, revenue from its Aerospace & Defense segment grew by 33.8% over the past year to €105.96 million.

• Jump into the full analysis health report here for a deeper understanding of Summa Defence Oyj.
• Evaluate Summa Defence Oyj's historical performance by accessing our past performance report.

Next Steps

• Explore the 308 names from our European Penny Stocks screener here.
• Curious About Other Options? The end of cancer? These 33 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com